Nonsurgical Breast Enlargement Using an External Soft-Tissue Expansion System.

Nonsurgical Breast Enlargement Using an External Soft-Tissue Expansion System.
复制标题

DOI:
10.1097/00006534-200006000-00033
复制
发表时间:
2000-06
影响因子:
3.6
通讯作者:
S. Slavin
S. Slavin
中科院分区:
医学1区
文献类型:
--
作者:
S. Slavin

文献摘要

被引文献

相似文献

对拥有更大乳房感兴趣的女性中,只有不到 1% 选择通过植入乳房假体进行隆胸手术。本报告的目的是描述和测试非手术丰胸方法的功效,该方法基于受控的分散机械力时组织生长的能力。 17 名有志于丰胸的健康女性(年龄 18 至 40 岁)参加了一项单组研究。参与者被要求佩戴一个类似胸罩的系统,在 10 周的时间内对每个乳房施加 20 毫米汞柱的真空牵引力,每天 10 至 12 小时。在治疗期间和治疗后定期通过三种不同的方法测量乳房尺寸。通过在月经周期的同一阶段获得的磁共振成像扫描,对治疗前后的乳腺组织水密度和结构进行可视化。十二名受试者完成了研究;由于不遵守协议,发生了五次提款。在 10 周的治疗过程中,所有女性的乳房尺寸均有所增加,并在第 10 周(最终治疗)达到顶峰;每个女性的平均体型比起始体型增加了 98±67%。治疗结束后的第一周就出现了部分反冲,在长达 30 周的随访后,尺寸没有进一步明显减小。乳房尺寸的长期稳定增长为 55%(范围为 15% 至 115%)。磁共振图像显示没有水肿,并证实脂肪和纤维腺组织成分成比例增大。在研究过程中,体重出现了统计学上的显着下降,自尊问卷得分也显着提高。所有参与者都对结果非常满意,并表示该设备佩戴舒适。在使用该装置期间或治疗后没有记录到不良事件。我们的结论是,通过日常使用适当设计的外部扩张系统可以实现真正的乳房增大。这种非手术和非侵入性的丰胸替代方法有效且耐受性良好。
Less than 1 percent of the women interested in having larger breasts elect to have surgical augmentation mammaplasty with insertion of breast implants. The purpose of this report is to describe and test the efficacy of a nonsurgical method for breast enlargement that is based on the ability of tissues to grow when subjected to controlled distractive mechanical forces. Seventeen healthy women (aged 18 to 40 years) who were motivated to achieve breast enlargement were enrolled in a single-group study. The participants were asked to wear a brassiere-like system that applies a 20-mmHg vacuum distraction force to each breast for 10 to 12 hours/day over a 10-week period. Breast size was measured by three separate methods at regular intervals during and after treatment. Breast tissue water density and architecture were visualized before and after treatment by magnetic resonance imaging scans obtained in the same phase of the menstrual cycle. Twelve subjects completed the study; five withdrawals occurred due to protocol noncompliance. Breast size increased in all women over the 10-week treatment course and peaked at week 10 (final treatment); the average increase per woman was 98±67 percent over starting size. Partial recoil was seen in the first week after terminating treatment, with no significant further size reduction after up to 30 weeks of follow-up. The stable long-term increase in breast size was 55 percent (range, 15 to 115 percent). Magnetic resonance images showed no edema and confirmed the proportionate enlargement of both adipose and fibroglandular tissue components. A statistically significant decrease in body weight occurred during the course of the study, and scores on the self-esteem questionnaire improved significantly. All participants were very pleased with the outcome and reported that the device was comfortable to wear. No adverse events were recorded during the use of the device or after treatment. We conclude that true breast enlargement can be achieved with the daily use of an appropriately designed external expansion system. This nonsurgical and noninvasive alternative for breast enlargement is effective and well tolerated.